Reports Q4 revenue $49.3B, consensus $49.43B. Gail Boudreaux President and CEO: “Elevance Health (ELV) delivered fourth quarter results in line with our outlook, reflecting disciplined execution in a dynamic environment. As we enter 2026, our focus is on advancing affordability and making healthcare easier to access and navigate for the members we serve. Through pricing discipline and targeted investments, we are strengthening the earnings power of our diversified platform and remain confident in our ability to return to at least 12% adjusted EPS growth in 2027.”
Claim 30% Off TipRanks
- Unlock hedge fund-level data and powerful investing tools for smarter, sharper decisions
- Discover top-performing stock ideas and upgrade to a portfolio of market leaders with Smart Investor Picks
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on ELV:
- Trump Trade: U.S. to raise tariffs on South Korean goods to 25%
- Deutsche says CMS rate notice ‘significant negative’ for managed care
- Is UnitedHealth Stock (UNH) a Buy Ahead of Q4 Earnings?
- Cantor Fitzgerald says quick health insurers recovery after CMS call ‘unlikely’
- CMS releases 2027 Medicare Advantage rate plan calling for 0.09% increase